High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies

Pseudomyxoma peritonei (PMP) is a rare, slow-growing cancer with few efficacious treatment options in unresectable cases. Mutations in the KRAS and GNAS oncogenes are common, but the reported frequencies vary greatly, most likely because of low tumor cellularity in peritoneal tumor samples. With tre...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Torgunrud Annette, Lund-Andersen Christin, Davidson Ben, Nitschke Marcussen Ina Katrine, Larsen Stein G., Dagenborg Vegar, Flatmark Kjersti
Formato:	Artigo
Idioma:	Inglês
Publicado em:	De Gruyter 2025-12-01
coleção:	Pleura and Peritoneum
Assuntos:	pseudomyxoma peritonei kras mutation gnas mutation oncogenes targeted therapy
Acesso em linha:	https://doi.org/10.1515/pp-2025-0034
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!